[go: up one dir, main page]

DK200201483A - Dermatologisk anvendelse og dermatologisk præparat - Google Patents

Dermatologisk anvendelse og dermatologisk præparat Download PDF

Info

Publication number
DK200201483A
DK200201483A DK200201483A DKPA200201483A DK200201483A DK 200201483 A DK200201483 A DK 200201483A DK 200201483 A DK200201483 A DK 200201483A DK PA200201483 A DKPA200201483 A DK PA200201483A DK 200201483 A DK200201483 A DK 200201483A
Authority
DK
Denmark
Prior art keywords
dermatological
application
preparation
acid
dermatological preparation
Prior art date
Application number
DK200201483A
Other languages
Danish (da)
English (en)
Inventor
Heino Pekka
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of DK200201483A publication Critical patent/DK200201483A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
DK200201483A 2000-04-06 2001-02-05 Dermatologisk anvendelse og dermatologisk præparat DK200201483A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste
PCT/FI2001/000100 WO2001076589A1 (fr) 2000-04-06 2001-02-05 Preparation dermatologique et son utilisation

Publications (1)

Publication Number Publication Date
DK200201483A true DK200201483A (da) 2002-10-03

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200201483A DK200201483A (da) 2000-04-06 2001-02-05 Dermatologisk anvendelse og dermatologisk præparat

Country Status (14)

Country Link
US (2) US20030144359A1 (fr)
EP (1) EP1274416A1 (fr)
JP (1) JP2003530349A (fr)
AU (1) AU2001235506A1 (fr)
CA (1) CA2405425A1 (fr)
CH (1) CH695983A5 (fr)
DE (1) DE10196025T1 (fr)
DK (1) DK200201483A (fr)
ES (1) ES2193003B1 (fr)
FI (1) FI107018B (fr)
GB (1) GB2377380B (fr)
NO (1) NO20024810L (fr)
SE (1) SE0202886L (fr)
WO (1) WO2001076589A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0831769T3 (da) * 1995-06-07 2004-02-23 Karobio Ab Hidtil ukendte anvendelser af thyroideahormoner eller thyroideahormon-lignende forbindelser
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
EP2335694B1 (fr) * 2003-09-15 2018-06-13 NanoPharmaceuticals LLC Analogues des hormones thyroidiennes et leur utilisation
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
WO2007035612A2 (fr) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Composes de liaison rgd et leurs procedes d'utilisation
EP2120913B1 (fr) 2006-12-22 2015-01-21 NanoPharmaceuticals LLC Formulations de nanoparticules et de polymères pour les analogues, les antagonistes et les formulations de l'hormone thyroïde et leurs utilisations
WO2010075332A1 (fr) * 2008-12-23 2010-07-01 Charitable Leadership Foundation Ligands à petites molécules du site de reconnaissance rgd de l'intégrine et méthodes d'utilisation
WO2010120506A1 (fr) 2009-03-31 2010-10-21 Ordway Research Institute, Inc. Polythérapie anticancéreuse par cétuximab et tétrac
CA2765792C (fr) 2009-06-17 2017-03-28 Ordway Research Institute, Inc. Formulations nanoparticulaires et polymeres pour hormone thyroidienne, analogues, antagonistes et formulations et utilisations de celles-ci
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
JP7074749B2 (ja) 2016-06-07 2022-05-24 ナノファーマシューティカルズ エルエルシー αｖβ３インテグリン甲状腺アンタゴニストにコンジュゲートした非開裂性ポリマー
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
CA2184002A1 (fr) * 1994-02-23 1995-08-31 Jeffrey M. Blaney Procede et compositions permettant de prolonger la demi-vie serique d'agents a activite pharmacologique
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
DK0831769T3 (da) * 1995-06-07 2004-02-23 Karobio Ab Hidtil ukendte anvendelser af thyroideahormoner eller thyroideahormon-lignende forbindelser
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
DE60028957T2 (de) * 1999-04-26 2007-02-15 Danforth Jun., Elliot Pharmazeutische zusammensetzungen enthaltend tetrac sowie deren verwendungsverfahren
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
GB2377380B (en) 2004-07-14
WO2001076589A1 (fr) 2001-10-18
FI107018B (fi) 2001-05-31
CA2405425A1 (fr) 2001-10-18
NO20024810L (no) 2002-12-06
CH695983A5 (de) 2006-11-15
EP1274416A1 (fr) 2003-01-15
AU2001235506A1 (en) 2001-10-23
US20030144359A1 (en) 2003-07-31
GB2377380A (en) 2003-01-15
ES2193003B1 (es) 2005-02-01
JP2003530349A (ja) 2003-10-14
SE0202886L (sv) 2002-12-02
NO20024810D0 (no) 2002-10-04
SE0202886D0 (sv) 2002-10-01
FI20000818A0 (fi) 2000-04-06
ES2193003A1 (es) 2003-10-16
DE10196025T1 (de) 2003-03-13
US20050272817A1 (en) 2005-12-08
GB0222880D0 (en) 2002-11-13

Similar Documents

Publication Publication Date Title
DK200201483A (da) Dermatologisk anvendelse og dermatologisk præparat
ATE162399T1 (de) Terfanadin metaboliten und deren optisch reine isomere zur behandlung von allergischen krankheiten
HK68085A (en) Preparations containing methylsulfonylmethane and method of purification
BR9408478A (pt) Composto composição farmacéutica processos de tratmento de uma doença suscetível ao tratamento com agente anti-inflamatório não esteroidal e de tratamento de doenças medidas pela ciclo-oxigenase, sal farmaceuticamente eficaz e uso de um composto
DE69815122D1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
IT8024370A1 (it) Composizione terapeutica di dimetil solfossido e procedimenti per il suo impiego
DE69418601D1 (de) Guanidinderivate mit therapeutischer wirkung
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
WO2001028491A3 (fr) Procede et composition utilises afin de traiter les affections dermatologiques
ITMI950575A0 (it) Preparati igienici e cosmetici per prevenire e trattare malattie della pelle nonche' procedimento per il loro ottenimento
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
PT920865E (pt) Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos
KR960010002A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
PL330768A1 (en) Perpetration for use in therapy and prophylactics of dermatological diseases
WO2001012214A3 (fr) Mofetilmycophenolate associe a peg-ifn-alpha
DE59905230D1 (de) Hyperforin-salbe oder -creme
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
MA26726A1 (fr) Composition pharmaceutique de resorcinol, et procede pour sa preparation
KR880005920A (ko) 인체의 백혈구 인터페론 조성물과 피부 치료법
AR025549A1 (es) Mofetil micofelonato en asociacion con peg-ifn-alfa
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
IT1211103B (it) Sostanza medicamentosa ad impiego topico per il trattamento delle affezioni provocate dalla seborrea sul cuoio capelluto umano.
ITRM910756A0 (it) Miscela di biofarmaci somministrabile per fleboterapia nel trattamentodelle patologie neuro-psico-somatiche e organico-vascolari, in particolare arteriopatie diabetiche e nicotiniche, cardiopatie ischemiche, tossicodipendenze, psoriasi
RU94038468A (ru) Способ в.ф.можаровского комплексного этиологического лечения псориаза противовирусным и противомикробными препаратами "ликвацид", "тринол", "трисолид" и "тротицид"
NO20006260L (no) Farmasöytisk sammensetning på basisen av erytromycin- fettsyresalter til topisk behandling av hudsykdommer

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment